-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury

Dow Jones·08/13/2026 11:30:00

Please log in to view news